Lauren C. Leiman

Executive Director at BloodPAC

Lauren Leiman is currently the Executive Director of the Blood Profiling Atlas in Cancer (BloodPAC), a consortium focused on creating an open database for liquid biopsies to accelerate the development of safe and effective blood profiling diagnostic technologies for patient benefit. Prior to running BloodPAC, she was the Senior Director of External Partnerships at White House Cancer Moonshot Task Force during the Obama Administration.

Previously, Lauren was a Senior Advisor for the Melanoma Research Alliance and Director of Philanthropy at Elysium Management LLC in New York City. From 2008-2010, Lauren worked for the Millennium Promise Alliance, where she led the major gifts fundraising effort and spent significant time in sub-Saharan Africa. Lauren was also the head of marketing and investor relations at Steel Partners, LP, an activist hedge fund investing globally.

Lauren received her undergraduate degree in communications from the University of Pennsylvania’s Annenberg School. She also holds an MBA in international business from the University of North Carolina’s Kenan-Flagler Business School and a master’s degree in public relations and corporate communications from NYU.


Title: BloodPAC Consortium: An Update on Establishing Standards, Accelerating Data Sharing and Analysis

  • Genesis of Pre-Analytical Minimal Technical Data Elements and Support from the FDA
  • Establishment of FDA supported Generic Analytical Validation Protocols and What’s Next
  • Developing the BloodPAC Data Commons into is a source of valid scientific evidence

Past Presentations

1. CDx & Biomarkers Summit 2019 - Accelerating Development of Liquid Biopsy technology